Phase 3 Study to Evaluate Efficacy of Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS)

NCT02970162 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Lambert-Eaton Myasthenic Syndrome

Interventions

DRUG: Amifampridine Phosphate
DRUG: Placebo Oral Tablet

Sponsor

Catalyst Pharmaceuticals, Inc.